LUNAR: a randomized Phase 2 study of 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).
Ting Martin MaJohannes CzerninCarol FelixRejah AlanoHolly WilhalmeLuca ValleMichael L SteinbergMagnus DahlbomRobert E ReiterMatthew B RettigMinsong CaoJeremie CalaisAmar U KishanPublished in: BJU international (2023)
Lu-PNT2002 to SBRT in patients with oligorecurrent mHSPC.
Keyphrases